Stocks · Health care · Pharmaceutical Preparations

Corbus Pharmaceuticals Holdings, Inc.

CRBP Clue Score27

United States Fiscal year ends December CIK 0001595097 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Cormorant Asset Management, LP

29 Oct 2026

Former 10% Owner

Sell indirect

425,000

$4.10

$1.74M

Dominic Smethurst

2 Mar 2026

Chief Medical Officer

Sell

6,097

$8.30

$50.60K

Ian Hodgson

17 Feb 2026

Chief Operating Officer

Sell

847

$7.38

$6.25K

Ian Hodgson

3 Feb 2026

Chief Operating Officer

Sell

2,415

$8.09

$19.54K

Dominic Smethurst

3 Feb 2026

Chief Medical Officer

Sell

3,285

$8.09

$26.57K

Cormorant Asset Management, LP

11 Dec 2025

10% owner

Sell indirect

30,029

$11.46

$344.01K

Show all 17 transactions →

What was left out

Form 4 filings counted 28

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 8

Sales straight out of an exercise 0

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 277,945

History held since 26 Nov 2014